Related Links:
For additional information regarding the ROX Solution, please refer to the following links.
- Venous Admixture in COPD: COPD: Journal of COPD
- Percutaneous Creation of...: Vascular Disease Management
- An Arteriovenous Fistula Increase Exercise Capacity in Patients with COPD: CHEST
The ROX® Medical Anastomotic Coupler System (ACS) is intended for use in patients with stage III and IV, severe Chronic Obstructive Pulmonary Disease (COPD) patients. The goal of the fistula is to increase cardiac output and improve oxygen saturation (including oxygen delivery to tissue and muscles) in patients suffering from hypoxia and hypoxemia. Potential benefits may include improved breathing, reduced symptoms of chronic bronchitis, and exercise tolerance. It is possible that the procedure may increase the oxygen content (CaO2) in patients with hypoxemia, and the cardiac output (CO), thereby increasing oxygen delivery to tissues (DO2). COPD patients may be able to walk farther, experience reduction in their severe COPD symptoms, and their quality of life may improve.
For more about ROX’s experimental COPD treatment, click here.
To see if your acute COPD qualifies you to participate in a COPD WALK™ Trial in your area, please click here.
